Article Information
History
- July 10, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Carleen Klumpp-Thomas1,2,
- Heather Kalish3,
- Jennifer Hicks3,
- Jennifer Mehalko4,
- Matthew Drew4,
- Matthew J Memoli5,
- Matthew D Hall1,
- Dominic Esposito4 and
- Kaitlyn Sadtler2,†
- 1National Center for Advancing Translational Sciences, National Institutes of Health, Rockville MD, 20850
- 2Section on Immuno-Engineering, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda MD 20894
- 3Trans-NIH Shared Resource on Biomedical Engineering and Physical Science, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda MD 20894
- 4Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD 21702
- 5LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute for Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20894
- ↵†address correspondence to: kaitlyn.sadtler{at}nih.gov
Posted July 10, 2020.
D614G Spike Variant Does Not Alter IgG, IgM, or IgA Spike Seroassay Performance
